Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Tesetaxel once every 3 weeks|DRUG: Tesetaxel once weekly
Sponsor: Genta Incorporated